Cefralin

Quick links to important sections

Cefralin

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cefralin

This foundational section defines the identity, classification, and general purpose of the prescription-only medicine Cefralin, which contains the active ingredient Cefdinir.

Property Description
Active ingredient Cefdinir
Form Capsule, Oral Suspension
Pharmacological class Second-Generation Cephalosporin Antibiotic
Common use Treating susceptible bacterial infections
Origin Semi-synthetic

What Type of Medicine is Cefralin (Cefdinir)?

Cefralin is a prescription-only medicine whose active ingredient is Cefdinir, classified as a semi-synthetic cephalosporin antibiotic. It functions as a powerful bactericidal agent used to combat susceptible bacterial infections throughout the body.

Cefdinir (C14H13N5O5S2) belongs to the family of beta-lactam antibiotics and is specifically identified as a second-generation cephalosporin. This class is clinically recognized for its improved stability against certain bacterial defense mechanisms compared to first-generation agents. The term semi-synthetic indicates that the compound is chemically derived and modified from a naturally occurring structure. Understanding this classification is crucial as it informs the general action: Cefralin is designed to kill a broad-spectrum of bacterial pathogens.

Cefralin's Form and High-Level Composition

Cefralin is a single-active-ingredient product available for oral administration in two primary dosage form(s): a solid capsule and a liquid oral suspension. The drug’s distinctive quality is the availability of the suspension form, often flavored for easier acceptance by pediatric patients.

The composition is centered entirely on the Cefdinir active substance, but it also includes various pharmaceutical excipients necessary to create the final stable and administrable forms. The provision of both a capsule for adult use and a flavored oral suspension ensures that the bactericidal agent can be delivered effectively via the non-invasive oral route across different age groups. This flexibility in dosage form is a differentiating factor.

What is the General Purpose of Cefralin?

The general purpose of Cefralin is to help the body eliminate bacterial infections by actively destroying the offending bacteria through a process called bactericidal action.

Cefralin achieves this effect by targeting and interfering with the ability of bacteria to maintain their protective cell walls. This action is rooted in the drug's mechanism of causing inhibition of bacterial cell wall synthesis, which leads to the structural compromise and death of the bacterial cells. Its classification as a second-generation cephalosporin means it possesses enhanced resistance to certain bacterial defense enzymes (beta-lactamases), allowing it to remain effective against a wider range of targets in typical infection scenarios.

What side effects are possible with Cefralin?

Cefralin (Cefazolin is a common related drug) is generally well-tolerated, but like all medications, it can cause side effects. These are typically mild and often resolve on their own, but some can be serious.

Common Side Effects

The most frequently reported side effects are related to the gastrointestinal system and typically include:

  • Diarrhea (sometimes watery)
  • Nausea and Vomiting
  • Loss of appetite
  • Stomach pain or cramps

Other common effects may include headache, oral or vaginal yeast infections (candidiasis), and local reactions such as pain, swelling, or redness at the injection site.

Serious Side Effects: Seek Immediate Medical Attention

Contact a healthcare provider immediately or seek emergency medical care if you experience any signs of a serious reaction or complication:

  • Severe Allergic Reaction (Anaphylaxis): Hives, itching, swelling of the face, throat, or tongue, difficulty breathing, or wheezing.
  • Severe Diarrhea: Watery, persistent, or bloody stools accompanied by severe abdominal cramping and fever, which could indicate a serious infection like Clostridium difficile-associated diarrhea.
  • Skin Reactions: Blistering, peeling, or loosening of the skin (including inside the mouth), accompanied by fever or flu-like symptoms (signs of Stevens-Johnson syndrome or Toxic Epidermal Necrolysis).
  • Liver or Kidney Problems: Yellowing of the skin or eyes (jaundice), dark urine, pale stools, significant decrease in the amount of urine, or unusual bruising or bleeding.

Safety Information and Precautions

Before taking Cefralin, inform your doctor about any history of allergies to penicillin or other cephalosporin antibiotics, as a cross-reaction may occur. Caution is advised for patients with a history of gastrointestinal disease (especially colitis) or kidney impairment, as dosage adjustments or close monitoring may be necessary. If you are diabetic, this medication may interfere with certain urine sugar tests.

Overdose and Emergency Response

Cefralin Overdose and when to seek help

The official regulatory profile for Cefralin (Cefdinir) strictly defines the manifestations of an acute overdose and the required emergency response.


Documented Overdose Presentations

Overdose presentations are primarily associated with the Central Nervous System (CNS). Documented clinical manifestations observed in these situations include encephalopathy, convulsions, excitability, and hyperkinesia. Non-specific symptoms such as nausea, vomiting, and epigastric distress are also officially recognized in regulatory labeling. The risk of developing severe neurological symptoms, including convulsions, is specifically noted to be heightened in patients with compromised renal function due to impaired drug clearance. Close clinical observation and monitoring are therefore required.


Required Emergency Actions

In the event of a suspected acute overdose, immediate medical attention is required. Official instructions mandate that individuals must contact emergency services immediately or be taken to a hospital emergency room. Treatment is strictly symptomatic and supportive, as the official labeling confirms that no specific antidote is known for Cefdinir. Procedures to reduce absorption, such as gastric lavage, may be utilized if the ingestion was recent. Hemodialysis may be considered as a procedure to remove the drug, though its efficacy in the context of overdose is not fully established in official documents.

Therapeutic Uses of Cefralin

What Cefralin Treats: Main Uses and Benefits

Cefralin is commonly used to help with conditions characterized by periods of heightened symptoms that involve bacterial infection. It is relevant in contexts marked by increased discomfort or tension across various body systems, addressing symptom patterns associated with the infectious agent.

Treating Acute Symptoms and Conditions

This medication helps address symptom clusters that may become intense or disruptive, such as symptoms related to heightened physiological activity (like fever) and discomfort caused by the infection. It is considered relevant in contexts involving heightened systemic burden and applied in clinical settings that involve acute or unstable symptom patterns, such as for surgical prophylaxis, where it may assist with managing the risk of post-operative infection.

The overall therapeutic purpose supports the patient during difficult episodes by easing distress. It contributes to improved comfort during periods of heightened symptoms and helps maintain a sense of stability for the patient.

Quick Fact: Relief for Systemic Discomfort
Cefralin assists with managing symptoms related to systemic imbalance, which may assist with maintaining functional stability during symptomatic phases.

Regulatory References

  1. Philippine Food and Drug Administration

Eligibility and Restrictions for Use

Who can and cannot use Cefralin?

Cefralin (Cefdinir) eligibility is defined by regulatory guidelines focusing on patient history, age, and organ function. The medication is contraindicated and must not be used in individuals with a known allergy to cefdinir or any other drug in the cephalosporin class of antibiotics.

Population Eligibility Status Regulatory Classification Restriction Condition (if applicable)
Established Use Adults, Adolescents, and Pediatric patients 6 months of age and older None, under standard labeled conditions
Use Not Established Infants younger than 6 months of age Safety and efficacy have not been established
Contraindicated Individuals with a history of cephalosporin allergy Absolute non-eligibility for use

Eligibility for use is restricted in patients with markedly compromised renal function (Creatinine Clearance < 30 mL/min), including those on hemodialysis, as they require a mandatory total daily dose reduction. The FDA has assigned Cefralin to Pregnancy Category B, indicating conditional use during gestation. Caution is advised when prescribing to patients with a history of colitis or prescribing the oral suspension to diabetic patients due to its sucrose content.

What should I know about interactions with other medicines?

Cefralin Interactions with other medicines and products

Cefralin's official interaction profile is defined by pharmacokinetic alterations affecting absorption and renal clearance, alongside documented pharmacodynamic interactions.

Documented Interaction Constraints

Classification Detail
Interacting Medicines Probenecid, Warfarin, and Lanthanum Carbonate are explicitly listed as interacting substances in regulatory documents.
Substance Categories Antacids containing aluminum or magnesium, therapeutic iron supplements, loop diuretics, and aminoglycosides have documented interaction risks.
Mechanistic Basis Interactions are officially described as inhibition of renal excretion (by Probenecid) and reduction of absorption through chelation/complex formation (by Antacids and Iron) that lowers Cefdinir exposure.
Timing-Separation Rule Administration of aluminum- or magnesium-containing antacids or iron supplements must be separated from Cefralin by at least 2 hours to prevent a documented reduction in Cefdinir absorption.
Pharmacodynamic Effect Co-administration with Warfarin has been associated with officially documented changes in the International Normalized Ratio (INR), reflecting an increased bleeding risk.
Population Note Systemic exposure is officially reported as substantially increased in elderly patients due to age-related reduction in renal clearance.

Connection to the Overall Interaction Profile

The regulatory documentation formally establishes that Cefralin's interaction structure primarily involves substances that affect its systemic concentration or its effect on blood coagulation. This structure is defined by mandatory administration spacing to mitigate reduced absorption and official warnings regarding co-medications that may significantly increase plasma levels or impact renal function. No medicinal products are formally classified as absolutely contraindicated.

Mechanism of Action

How Cefralin Works

Cefralin (Cefdinir) acts exclusively by a bactericidal mechanism, targeting the construction process of bacterial cells. The drug’s function is defined by its interaction with key enzymatic systems and the resulting failure of the bacterial structure.

Covalent Inhibition of Bacterial Construction Enzymes

Cefralin’s primary molecular targets are the Penicillin-Binding Proteins (PBPs), essential enzymes required for cell wall assembly. Cefralin operates as a covalent inhibitor, forming an irreversible bond with the active site serine residue of the PBP enzyme. This action results in the immediate arrest of the bacterial cell wall synthesis pathway.

Disruption of Peptidoglycan Cross-Linking

By blocking the final transpeptidation step of the peptidoglycan pathway, the drug prevents the bacteria from assembling a rigid protective wall. This molecular failure produces the physiological consequence of rendering the bacterial cell unable to withstand its own internal osmotic pressure, triggering cell lysis (rupture). This highly specific destructive action is the molecular basis for pathogen elimination.

Functional Constraints and Mechanism Limitations

This mechanism is inherently ineffective against bacteria with altered PBP structures (low affinity binding) or those that actively destroy the drug using beta-lactamase enzymes. These constraints limit the drug's action against certain resistant pathogens, defining the biological boundaries of the mechanism.

Dosage and Administration Information

How to Use Cefralin

Cefralin (Cefdinir) is strictly an oral prescription medicine, available as a 300 mg capsule and as a powder that must be reconstituted to create an oral suspension. The instructions for use detail the required administration route, dose quantity, frequency, and typical duration for the medication.


Administration Parameter Instruction
Route Oral only (capsule or suspension).
Standard Adult Dose Total daily dose of 600 mg.
Frequency Administered as 300 mg every 12 hours (BID) or 600 mg every 24 hours (QD). BID dosing is indicated for certain conditions, such as pneumonia and skin structure infections.
Duration The course of treatment typically ranges from 5 to 10 days.

Contextual Use and Adjustments

The medicine may be taken without regard to meals. To ensure proper systemic delivery, Cefralin must be administered at least two hours before or after iron supplements or antacids containing aluminum or magnesium.

The liquid oral suspension must be prepared by reconstituting the powder with water, and the final suspension should be shaken well before each use. Once prepared, the product is stable for 10 days at room temperature.

For adults with severely reduced kidney function (creatinine clearance <30 mL/min), the total daily dose must be reduced to 300 mg taken once every 24 hours. If a dose is missed, the recommended approach is to take it as soon as remembered, unless it is close to the next scheduled dose; it is advised never to take a double dose.

Recent Clinical Evidence

Overview of Clinical Studies

This section summarizes the structure of Randomized Controlled Trials (RCTs) and comparative studies that evaluated the use of Cefralin for common upper respiratory, ear, and skin infections. These studies contribute to the broader evidence landscape about outcomes related to physical discomfort and acute changes in symptoms across different populations.


Evidence from Trials for Upper Respiratory Infections

Acute Otitis Media (AOM) and Pharyngitis

Research for acute ear infections primarily consisted of short-term controlled trials focused on pediatric subjects (6 months to 12 years). Researchers explored how symptoms change and measured the patient's clinical response (monitoring of ear pain and discharge) and microbiological eradication. Studies monitored responses over defined time intervals, and findings describe patterns observed in the treated cohorts.

For pharyngitis and tonsillitis, comparative trials examined treatment periods as short as five days, monitoring responses against those observed with 10-day courses of penicillin V. For acute bacterial sinusitis, research examined outcomes related to physical discomfort in adults and adolescents, where clinical success was monitored, including the monitoring of facial pain and pressure.


Key Limitations and Research Gaps

The evidence base shows several consistent limitations. Research is restricted to mild-to-moderate infections, and does not apply to severe or complicated cases, including Community-Acquired Pneumonia (CAP) or complex skin infections. Long-term effects are not fully established, and long-term outcomes are not well characterized in the available studies. Furthermore, data for children younger than 6 months of age remain insufficient, and efficacy is not established for this population.

Key Studies & References

  1. Cefdinir Capsule and Oral Suspension Official Labeling (DailyMed - NIH)

Frequently Asked Questions (FAQ)

Common questions about Cefralin (FAQ)

Q: What is the main reason doctors prescribe Cefralin?

Cefralin is officially indicated for treating mild to moderate bacterial infections in adults and children. These typically include conditions affecting the respiratory system, such as bronchitis and certain types of pneumonia or sinusitis, as well as ear and skin infections. The purpose of the medication is to eliminate these susceptible bacteria.


Q: Are there any common over-the-counter medicines that are known to interact with Cefralin?

Official product information indicates that certain common over-the-counter products can interact with Cefralin. Specifically, antacids containing aluminum or magnesium and iron supplements can significantly interfere with the drug's absorption. Regulatory documents describe that administration of these products should be separated by at least two hours from Cefralin to avoid a reduction in its absorption.


Q: Does Cefralin have any known long-term side effects?

Cefralin is an antibiotic typically prescribed for short courses, usually lasting between 5 and 10 days. The safety data available in official documents primarily focus on this short-term use. Consequently, the regulatory documentation does not fully characterize long-term side effects since the drug is not intended for extended use.


Q: Is Cefralin considered safe for use in older adults?

Official documents note that the body's exposure to Cefralin may be substantially increased in older adults. This is due to age-related changes that can reduce how efficiently the kidneys clear the drug from the system. Because of this, adjustments to the total daily dose are described in the official regulatory instructions for patients with compromised kidney function.


Q: What does the research say about Cefralin's effectiveness compared to a placebo?

Clinical studies evaluating Cefralin's use were generally conducted as randomized controlled trials that compared its effects to an established drug or a non-treatment control group. This research focused on measuring key clinical responses and the elimination of bacteria. Specific, detailed comparisons against a placebo are typically not the central focus of patient-facing summaries for prescription antibiotics.


Q: Does Cefralin require a special prescription in most countries?

Cefralin is formally classified as a prescription-only medicine in countries where it is regulated. It is not designated as a controlled substance by major government drug agencies. Therefore, while a prescription is always required, it is not typically considered a 'special' prescription requiring additional scheduling or controls.


Q: How is Cefralin eliminated from the body?

According to official documents, Cefralin is eliminated from the body principally through the kidneys via a process called renal excretion. Once taken, the drug has a relatively short mean plasma elimination half-life, meaning it is quickly removed from the bloodstream.


Q: Does the time of day I take Cefralin matter?

Cefralin can be taken without regard to meals, giving a high degree of flexibility regarding food. The most important factor is consistency, especially when prescribed to be taken once daily or in two divided doses. Maintaining a consistent administration time is described as important for supporting effective drug levels throughout the entire course of treatment.


Q: Are there any dietary restrictions I need to follow while taking Cefralin?

Official instructions state that you can take Cefralin without regard to food, meaning general dietary restrictions are not required for absorption. However, official instructions note the liquid oral suspension contains sucrose, which may be a consideration for patients managing diabetes. Additionally, the administration of Cefralin is described as needing separation from iron supplements and aluminum- or magnesium-containing antacids.


Q: What is the role of Cefralin in managing chronic versus acute conditions?

Cefralin is indicated for the management of acute bacterial infections, meaning those that have a rapid onset and typically a short duration. Examples of these uses include acute ear infections (otitis media) or acute worsening of chronic bronchitis caused by susceptible bacteria. The standard course of treatment reflects this purpose, usually lasting only 5 to 10 days.


Q: Why is patient compliance important when taking Cefralin?

Patient compliance is crucial for the effective action of Cefralin. Official patient information notes that if the full prescribed course of therapy is not completed, the treatment may be less effective. Most importantly, this non-compliance can increase the likelihood that the target bacteria will survive and develop resistance to the antibiotic.


Q: What does the term 'contraindicated' mean in relation to Cefralin?

In medical terms, when Cefralin is contraindicated for a condition, it means the medication must not be used under any circumstances if that specific condition is present. For Cefralin, the primary contraindication is a known history of allergy to the drug or any other medicine in the cephalosporin class. Official documents state that using the drug when contraindicated is discouraged due to the potential for adverse outcomes.


Q: Does Cefralin have any known interactions with herbal remedies or vitamins?

Official interaction warnings specifically focus on therapeutic iron supplements, which are commonly sold as vitamins. Because of the risk of reduced absorption, these supplements must be taken separately from Cefralin. Generally, patients are directed to inform their healthcare provider of all herbal remedies and vitamins they are taking due to the possibility of other undocumented or unknown interactions.


Q: How does the FDA classify the safety profile of Cefralin?

The FDA uses classifications for specific populations, such as assigning Cefralin to Pregnancy Category B. This classification indicates that while animal studies of the drug did not show a risk to the fetus, there are currently no adequate, well-controlled studies conducted in pregnant women. This categorization is used by healthcare providers when weighing the potential benefits against the risks.


Q: Can Cefralin make you feel tired or drowsy?

While tiredness or drowsiness are not listed among the most common side effects in the core clinical trials, post-marketing safety reports have included rare mentions of lethargy and drowsiness. Official adverse reaction sections also include infrequent reports of altered mental status.


Q: Does Cefralin interact with alcohol?

Official product information does not list a direct chemical interaction between Cefralin and alcohol. However, official advice cautions that the consumption of alcohol may contribute to or worsen some common side effects of the medication, such as headaches or nausea.


Q: Is Cefralin a controlled substance?

Cefralin is not classified as a controlled substance by regulatory agencies such as the U.S. Drug Enforcement Administration. It is designated as a prescription-only medicine that requires authorization from a licensed healthcare provider.


Q: Is there a generic version of Cefralin available?

Yes, the brand-name version of the drug has FDA-approved generic equivalents available. This means that versions containing the same active ingredient, Cefdinir, are available in the marketplace, consistent with official approvals.


Q: Is it true that Cefralin can affect birth control pills?

Official product literature sometimes mentions that Cefralin may interact with certain oral contraceptives (birth control pills). This potential for interaction is why the topic is included in the patient information provided by healthcare providers.


Q: Can Cefralin cause difficulty sleeping?

While not common, post-marketing reports of side effects have included instances of both the inability to sleep (insomnia) and, conversely, unusual drowsiness or sleepiness.


Q: Does Cefralin impact mental clarity or memory?

Based on post-marketing adverse event reports, there have been infrequent mentions of effects on mental function. These reports include instances of confusion and altered mental status.


Q: Do I need to finish the entire course of Cefralin if I start feeling better?

Official patient information emphasizes the importance of completing the full course of Cefralin as prescribed. It is common to feel better early in the treatment, but official information notes that stopping the medication prematurely may reduce its effectiveness and is associated with the possibility of the infection returning or becoming resistant.

How should Cefralin be stored and disposed of?

Storage Requirements

Cefralin (Cefdinir) storage conditions are defined by the dosage form. The capsules and the powder for oral suspension must be stored at 25^circmathrmC (77^circmathrmF), with controlled excursions permitted between 15^circmathrmC and 30^circmathrmC. All forms must be kept in a tightly closed container and protected from excess heat and moisture.

Dosage Form Storage Temperature Stability/Shelf-Life
Capsules / Powder Controlled Room Temperature Until Expiration Date
Reconstituted Liquid 20^circmathrmC to 25^circmathrmC OR Refrigerated 10 days maximum; must be discarded after this period.

Handling and Disposal

Before administration, the liquid suspension must be shaken well. As a mandatory safety requirement, Cefralin must be stored out of the sight and reach of children. Unused or expired medication should not be flushed down the toilet. Disposal should occur via an authorized drug take-back program or by mixing the product with an undesirable substance in a sealed container before discarding in household trash, following official guidance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cefralin found in:

A-Z Index: